Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

United Therapeutics (UTHR) Operating Margin (2016 - 2025)

Historic Operating Margin for United Therapeutics (UTHR) over the last 17 years, with Q3 2025 value amounting to 48.59%.

  • United Therapeutics' Operating Margin rose 27800.0% to 48.59% in Q3 2025 from the same period last year, while for Sep 2025 it was 62.63%, marking a year-over-year increase of 29200.0%. This contributed to the annual value of 47.86% for FY2024, which is 30500.0% down from last year.
  • As of Q3 2025, United Therapeutics' Operating Margin stood at 48.59%, which was up 27800.0% from 45.64% recorded in Q2 2025.
  • Over the past 5 years, United Therapeutics' Operating Margin peaked at 26010.0% during Q4 2023, and registered a low of 4527.85% during Q4 2024.
  • For the 5-year period, United Therapeutics' Operating Margin averaged around 1171.43%, with its median value being 48.59% (2025).
  • Per our database at Business Quant, United Therapeutics' Operating Margin soared by 259742700bps in 2023 and then tumbled by -305378500bps in 2024.
  • Over the past 5 years, United Therapeutics' Operating Margin (Quarter) stood at 40.9% in 2021, then decreased by -13bps to 35.73% in 2022, then soared by 72701bps to 26010.0% in 2023, then tumbled by -117bps to 4527.85% in 2024, then surged by 101bps to 48.59% in 2025.
  • Its Operating Margin stands at 48.59% for Q3 2025, versus 45.64% for Q2 2025 and 48.19% for Q1 2025.